Humacyte, Inc. (HUMAW) NASDAQ

0.27

-0.0451(-14.09%)

Updated at May 08 04:00PM

Currency In USD

Valuation

Market Cap598.32M
Enterprise Value569.92M
P/E Ratio-0.96
PEG Ratio-0.01
Price/Sales Ratio25.97
Price/Book Ratio-2.72
Enterprise/Revenue22.04
Enterprise/EBITDA-1.25

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-20.57
Operating Margin-15.83

Management Effectiveness

Return On Assets-1.08
Return On Equity5.02

Income Statement

Revenue0
Revenue/Share0.06
Gross Profit0
EBITDA-114.4M
Net Income0
Diluted EPS-1.26

Balance Sheet

Total Cash44.94M
Total Cash/Share0.38
Total Debt16.54M
Total Debt/Equity-0.31
Current Ratio2.4
Book Value Per Share-0.44

Price History

52-Week Change-63.21
52-Week High0.38
52-Week Low0.25
Moving Average 50 Days0.6
Moving Average 200 Days1.53

Statistics

Average Volume31,654.39
Shares Outstanding155.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A